ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,339.23
-0.37%
Dow Jones
39,082.88
-1.48%
Gold vs US Dollar
2,336.115
-1.92%
Brent Oil
80.805
-0.89%
Bitcoin
67,201.94
-2.75%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. XOMA Corporation (XOMA) Share Price

XOMA XOMA Corporation

25.80
0.60 (2.38%)
Last Updated: 18:49:41
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 XOMA Corporation NASDAQ:XOMA NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.60 2.38 25.80 25.64 25.75 25.80 25.45 25.45 875 17:49:41   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 4.76M -40.83M -3.5121 -7.31 298.67M
 Type  Size  Price  Time  Units 
 9 3 25.72 17:49:25 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore XOMA News
14/05/202412:30GLOBEXOMA to Present at H.C. Wainwright 2nd Annual Bioconnect Investor Conference at NASDAQ
09/05/202412:30GLOBEXOMA Reports First Quarter 2024 Financial Results and Highlights Recent Activities
30/04/202412:30GLOBEXOMA Adds Economic Interests in Three First-in-Category Assets to its Royalty and Milestone Portfolio Including XACIATO™ (clindamycin phosphate) Vaginal Gel 2%
25/04/202412:30GLOBEXOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One’s OJEMDATM (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG)
24/04/202414:00PRNUSActym Therapeutics Appoints Thomas Smart as CEO
03/04/202414:00GLOBEXOMA Corporation Announces Closing of Tender Offer
21/03/202411:30GLOBEXOMA Declares Quarterly Preferred Stock Dividends
Period
Draw mode
Data Downloads for XOMA

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest XOMA Corporation Articles